Brisbane, 08 June 2007: Progen Pharmaceuticals (ASX: PGL, NASDAQ: PGLA) today announced the appointment of Dr. James Garner as Vice President of Medical and Clinical Affairs, and Dr. John Devlin as Vice President of Manufacturing Operations. These appointments are intended to support the Company's efforts toward expediting the progression of its lead compound, PI-88 in post-resection liver cancer, to market.
